Religion
B.A.
Dartmouth College
1987
See all Profiles
Faculty
Faculty
Andrea A. Hayes-Dixon, MD, FACS, Ph.D.
Dean
Department/Office
- Dean's Office
School/College
- College of Medicine
Biography
Andrea A. Hayes-Dixon, MD, FACS, Ph.D., is the dean of the Howard University College of Medicine. She was appointed as the first Black woman to serve as dean of the Howard University College of Medicine in 2022. She completed a molecular biology fellowship at the University of California - San Francisco. She also completed a pediatric surgery fellowship at the Toronto Hospital for Sick Children. She also participated in a special fellowship in melanoma and sarcoma at the UT MD Anderson Cancer Center.
In 2024, she was appointed chair of the Scientific Management Review Board at the U.S. Department of Health and Human Services. This appointment will extend through June 2026. The Scientific Management Review Board plays a critical role in supervising and reviewing the management and operations of scientific research programs within the U.S. Department of Health and Human Services.
Before joining Howard University, Hayes-Dixon served as the Surgeon-in-Chief and Division Chief of Pediatric Surgery at the University of North Carolina Children's Hospital, where she was also a professor of Pediatric Surgery and Surgical Oncology. Additionally, she has served as the section chief of Pediatric Surgery at the University of Texas MD Anderson Cancer Center.
Hayes-Dixon became the first African American woman in the nation to achieve board certification in pediatric surgery in 2004. In addition, she was the first surgeon worldwide to perform a high-risk, life-saving procedure in teenagers with rare forms of abdominal cancer in 2006.
Education & Expertise
Education
M.D.
Geisel School of Medicine, Dartmouth College
1991
Publications and Presentations
Publications and Presentations
Artificial Intelligence Compared to Manual Selection of Prospective Surgical Residents
https://www.sciencedirect.com/science/article/abs/pii/S1931720424004562
Artificial Intelligence (AI) in the selection of residency program applicants is a new tool that is gaining traction, with the aim of screening high numbers of applicants while introducing objectivity and mitigating bias in a traditionally subjective process. This study aims to compare applicants screened by an AI software to a single Program Director (PD) for interview selection.
Embryonal sarcoma of the liver in pediatric and young adult patients: A report from Children’s Oncology Group study
Embryonal sarcoma of the liver (ESL) is a rare mesenchymal tumor most common in childhood; the optimal treatment approach is uncertain. The clinical features and outcomes of patients with ESL enrolled in a Children’s Oncology Group (COG) clinical trial that evaluated a risk-based strategy for treating soft tissue sarcomas in patients aged <30 years were evaluated.
Outcomes for patients with perineal and perianal rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma Committee
To describe clinical features, risk factors, and outcomes of patients with perineal and perianal rhabdomyosarcoma.
Observations on the Representation of Asians in Surgical Training and Leadership
https://www.sciencedirect.com/science/article/abs/pii/S0022480424001185
Diversity in medicine has a positive effect on outcomes, especially for Asian patients. We sought to evaluate representation of Asians across entry and leadership levels in surgical training.
Central Line-Associated Bloodstream Infection Risk Factors in a Pediatric Population
https://journals.sagepub.com/doi/full/10.1177/00031348231192070
Central venous line (CVL) placement in children is often necessary for treatment and may be complicated by central line-associated bloodstream infection (CLABSI). We hypothesize that line type and clinical and demographic factors at line placement impact CLABSI rates.